GlassScriptPhysician profile
Brooke Kindall
NPI 1063043263
$4,232.87
in general payments reported to CMS, 2019-2025
27 companies · $527 in 2025
The $527 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $461 · 2022: $2,176 · 2023: $530 · 2024: $539 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,415.93 | 2021-2024 | Axonics |
| Abbvie INC. | $833.06 | 2021-2025 | |
| Astellas Pharma US INC | $523.59 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $460.74 | 2023-2025 | Gemtesa, Myfembree |
| Mayne Pharma Commercial LLC | $160.92 | 2022-2024 | |
| Agile Therapeutics, INC. | $115.50 | 2021-2023 | Twirla |
| Pfizer INC. | $83.55 | 2022-2023 | |
| Coloplast Corp | $70.38 | 2024-2025 | |
| Hologic Sales and Service, LLC | $58.14 | 2021-2023 | Novasure, Coolseal Generator |
| Urovant Sciences INC | $58.08 | 2022 | |
| 180 Medical, INC. | $55.87 | 2022-2023 | Gentlecath Glide |
| Allergan, INC. | $42.76 | 2021-2022 | |
| Medtronic, INC. | $42.13 | 2022 | |
| Therapeuticsmd, INC. | $35.75 | 2021-2022 | |
| Exeltis, USA INC. | $35.42 | 2022-2024 | Slynd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $31.81 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.09 | 2021 | |
| Organon LLC | $22.99 | 2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $22.97 | 2021 | |
| Acera Surgical, INC. | $22.10 | 2022 | |
| Evofem Biosciences, INC. | $19.37 | 2022 | |
| Ethicon US, LLC | $17.01 | 2022 | |
| Millicent US INC | $16.08 | 2025 | Femring, Intrarosa |
| Amgen INC. | $15.24 | 2021 | |
| Aspira Women'S Health INC | $15.23 | 2022 | |
| Bausch Health US, LLC | $14.62 | 2022 | |
| Myovant Sciences INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Kindall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.